PeptiDream Inc.

PeptiDream Inc.

PPTDF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$860.76M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
PeptiDream Inc.PeptiDream Inc.-47.4--6%-0.3
$1.33

Current Fair Value

80.2% downside

Overvalued by 80.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$860.76 Million
Enterprise Value$-3,766,548,088.00
Earnings per Share$-29.8
Beta0.53
Outstanding Shares128,567,724

Return

Return on Equity-6.00%ROE
Return on Assets-4.06%
Return on Invested Capital-5.95%

Valuation & Multiples

P/E Ratio-47.42P/E Ratio
PEG70.48PEG
Price to Sales0.04Price to Sales
Price to Book Ratio0.02Price to Book Ratio
Enterprise Value to Revenue6.46
Enterprise Value to EBIT-35.1
Enterprise Value to Net Income1
Total Debt to Enterprise0.12
Debt to Equity0.32Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 11, 2026
EPS
-$0.02
Est. -$0.04
Revenue
$35.54 M
Est. $32.12 M

Next Earnings Call

Expected Date
February 17, 2027
EPS Estimate
$0.29
Consensus analyst estimate
Revenue Estimate
$103.70 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About PeptiDream Inc.

763 employees
CEO: Patrick Crawford Reid

PeptiDream Inc. functions as a biopharmaceutical enterprise, concentrating on the identification and progression of therapeutic compounds such as constrained peptides, small molecules, and peptide-drug conjugates. The company's unique pr...